Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Makoto Shinozaki"'
Autor:
Ai Goto, Ryuichi Kambayashi, Hiroko Izumi-Nakaseko, Makoto Shinozaki, Yoshinori Takei, Atsushi Sugiyama
Publikováno v:
Journal of Pharmacological Sciences, Vol 152, Iss 4, Pp 201-209 (2023)
We simultaneously assessed electropharmacological effects of anti-atrial fibrillatory drug vernakalant and its potential risk toward torsade de pointes. Vernakalant hydrochloride in doses of 0.3 and 3 mg/kg/10 min was intravenously administered to is
Externí odkaz:
https://doaj.org/article/b956d5c03fd84d6aa6002752932fa2bc
Autor:
Ryuichi Kambayashi, Ai Goto, Mihoko Hagiwara-Nagasawa, Hiroko Izumi-Nakaseko, Makoto Shinozaki, Shinichi Kawai, Akio Matsumoto, Yoshinori Takei, Atsushi Sugiyama
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 4, Pp 343-350 (2022)
Although NMDA receptor antagonist memantine is considered to be better tolerated than cholinesterase inhibitors on treating Alzheimer's disease, several types of cardiovascular adverse events have been associated with memantine treatment, including h
Externí odkaz:
https://doaj.org/article/48ebbcb6e236469c8064a6bf1f7c8dbe
Autor:
Makoto Shinozaki, Hiroyuki Oguma, Masahiro Sekine, Yoshihiro Hosomi, Daisuke Sakamoto, Masaru Sano, Tomoya Kumagai, Hiroyuki Inoue
Publikováno v:
Seikei-Kakou. 27:102-108
Publikováno v:
International Journal of Environmental & Rural Development; Dec2020, Vol. 11 Issue 2, p98-103, 6p
Autor:
Hiroko Izumi-Nakaseko, Koki Chiba, Makoto Shinozaki, Ai Goto, Atsuhiko T. Naito, Yoshiki Kondo, Atsushi Sugiyama, Mihoko Hagiwara-Nagasawa, Ryuichi Kambayashi, Yoichi Tanikawa
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 92:3-O
Autor:
Makoto Shinozaki, Atsuhiko T. Naito, Yoshiki Kondo, Yoichi Tanikawa, Ryuichi Kambayashi, Atsushi Sugiyama, Ai Goto, Koki Chiba, Mihoko Hagiwara-Nagasawa, Hiroko Izumi-Nakaseko
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 92:1-SS
Publikováno v:
Journal of Materials Science. 43:2234-2239
Eu doped Y2O3 and some kinds of other rare earth oxides nanoparticles such as Er2O3, Nd2O3, Ho2O3, Lu2O3, and Dy2O3 were prepared by a simple co-precipitation-solvothermal treatment-calcination process, where the co-precipitated amorphous hydroxide p
Publikováno v:
Dokkyo journal of medical sciences. 33(1):35-41
Heart failure patients have been shown to have an increased blood norepinephrine concentration, and patients with a high norepinephrine concentration have a poor prognosis. Norepinephrine is a catecholamine with α_1 and β_1 effects, which lead to a
Norepinephrine-induced diastolic dysfunction with aortic valve opening under calcium-loading in rats
Autor:
Ryuko Matsuda, Hisashi Hasumi, Noboru Kaneko, Naoyuki Ohtani, Kazuhiko Oda, Ken Shimamoto, Takahide Nakajima, Makoto Shinozaki
Publikováno v:
Drug Development Research. 67:511-518
Heart failure associated with a high plasma level of norepinephrine (NE) has an extremely poor prognosis with NE being the most powerful predictor of all-cause mortality. An increase in the diastolic intracellular calcium level (Ca2+) occurs in left
Publikováno v:
Dokkyo journal of medical sciences. 32(2):91-98
拡張不全は左室収縮の低下を伴わない心不全で,左室収縮の低下による収縮不全とは病態,基礎疾患,予後が異なることが明らかにされつつある.しかし,その発生メカニズムについては十分